gip/glp-1 tirzepatide Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy GLP-1 + GIP Injections -
Description
Cambridge University Hospitals NHS Your Obesity Treatment: Tirzepatide (Mounjaro) 8
Use a 0.3 ml (30-unit) syringe for doses under 25 units whenever possible
Its main side effects match those seen with Retatrutide: nausea, vomiting, and diarrhea are most common
Do not eat or drink for six hours before your procedure
Research suggests that people experiencing weight loss may benefit from higher protein intake than usual to support hair health
